PDSB CIK: 1472091

PDS Biotechnology Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
66.8
FY22:
76.5
FY23:
59.1
FY24:
45.1
FY25:
28.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.36
FY22:
0.53
FY23:
0.34
FY24:
0.30
FY25:
2.24
Total assets
Change from FY21 to FY25
millions USD
FY21:
67.2
FY22:
77.0
FY23:
59.4
FY24:
45.4
FY25:
30.5

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
3.76
FY22:
9.82
FY23:
13.6
FY24:
17.1
FY25:
9.48
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.23
FY22:
23.2
FY23:
19.6
FY24:
9.27
FY25:
11.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
63.2
FY22:
44.0
FY23:
26.1
FY24:
19.0
FY25:
9.25
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
67.2
FY22:
77.0
FY23:
59.4
FY24:
45.4
FY25:
30.5

All amounts in millions USD Data source:SEC EDGAR